Your browser is no longer supported. Please, upgrade your browser.
AVITA Medical, Inc.
Index- P/E- EPS (ttm)-1.19 Insider Own1.20% Shs Outstand24.85M Perf Week-2.25%
Market Cap457.80M Forward P/E- EPS next Y-1.29 Insider Trans-9.90% Shs Float24.51M Perf Month-0.76%
Income-26.60M PEG- EPS next Q-0.38 Inst Own39.50% Short Float5.42% Perf Quarter-17.30%
Sales29.20M P/S15.68 EPS this Y43.40% Inst Trans22.97% Short Ratio9.29 Perf Half Y-12.03%
Book/sh4.65 P/B3.92 EPS next Y10.40% ROA-26.70% Target Price- Perf Year-24.28%
Cash/sh4.40 P/C4.14 EPS next 5Y- ROE-29.60% 52W Range16.52 - 28.49 Perf YTD-1.99%
Dividend- P/FCF- EPS past 5Y- ROI-23.00% 52W High-36.08% Beta1.02
Dividend %- Quick Ratio16.20 Sales past 5Y- Gross Margin80.20% 52W Low10.23% ATR0.72
Employees98 Current Ratio16.40 Sales Q/Q126.10% Oper. Margin-90.60% RSI (14)46.34 Volatility4.05% 3.49%
OptionableYes Debt/Eq0.00 EPS Q/Q- Profit Margin-90.90% Rel Volume0.34 Prev Close18.39
ShortableYes LT Debt/Eq0.00 EarningsAug 26 AMC Payout- Avg Volume142.95K Price18.21
Recom1.60 SMA20-4.97% SMA50-2.96% SMA200-11.18% Volume49,002 Change-0.98%
Mar-02-21Initiated Piper Sandler Overweight $27
Aug-27-20Initiated BofA Securities Buy $42
Apr-21-20Initiated Oppenheimer Outperform $9
Mar-03-20Initiated BTIG Research Buy $10
Sep-13-21 04:01PM  
Aug-31-21 04:01PM  
Aug-26-21 04:01PM  
Aug-16-21 08:00AM  
Aug-12-21 04:01PM  
Jun-29-21 04:23PM  
Jun-15-21 06:08PM  
Jun-10-21 09:00AM  
Jun-01-21 04:01PM  
May-13-21 04:01PM  
Apr-29-21 04:01PM  
Apr-15-21 08:00AM  
Apr-14-21 12:00PM  
Mar-30-21 04:01PM  
Mar-22-21 08:00AM  
Mar-01-21 06:33PM  
Feb-25-21 12:30AM  
Feb-24-21 04:01PM  
Feb-18-21 04:01PM  
Feb-11-21 04:01PM  
Feb-07-21 12:16PM  
Feb-03-21 04:01PM  
Jan-28-21 04:01PM  
Jan-22-21 08:01AM  
Jan-12-21 08:00AM  
Dec-28-20 05:00PM  
Dec-15-20 08:00AM  
Dec-01-20 08:00AM  
Nov-30-20 04:17PM  
Nov-18-20 04:01PM  
Nov-12-20 07:00PM  
Nov-10-20 04:01PM  
Nov-09-20 08:00AM  
Nov-05-20 10:30PM  
Nov-03-20 04:01PM  
Oct-29-20 07:29PM  
Oct-28-20 04:01PM  
Oct-27-20 04:01PM  
Sep-14-20 08:00AM  
Sep-06-20 09:21PM  
Sep-03-20 04:01PM  
Aug-26-20 08:00AM  
Jul-29-20 04:01PM  
Jul-13-20 08:00AM  
Jul-09-20 08:00AM  
Jul-08-20 05:34PM  
Jun-29-20 12:31AM  
Jun-22-20 11:49AM  
Jun-15-20 12:30AM  
Jun-14-20 06:46PM  
Jun-09-20 08:43PM  
Jun-04-20 09:00PM  
Jun-01-20 09:28PM  
May-27-20 03:58PM  
May-21-20 04:01PM  
May-13-20 04:01PM  
May-11-20 04:31PM  
May-09-20 08:30PM  
May-02-20 07:18AM  
Apr-29-20 01:10AM  
Apr-20-20 08:00AM  
Apr-06-20 08:00AM  
Apr-01-20 08:35PM  
Mar-25-20 10:59PM  
Mar-04-20 04:01PM  
Mar-03-20 04:05PM  
Mar-02-20 10:21PM  
Feb-19-20 01:04AM  
Feb-11-20 04:05PM  
Feb-08-20 06:32PM  
Jan-30-20 07:38PM  
Dec-29-19 06:49PM  
Dec-10-19 04:14PM  
Dec-05-19 02:15PM  
Nov-25-19 09:57AM  
Nov-17-19 08:37PM  
Nov-12-19 07:24PM  
Nov-07-19 07:31PM  
Oct-30-19 08:48PM  
Oct-26-19 07:46PM  
AVITA Medical Inc. operates as a commercial-stage regenerative tissue company in the United States, Australia, and the United Kingdom. It offers regenerative products to address unmet medical needs in burn injuries, trauma injuries, chronic wounds, and dermatological and aesthetics indications, including vitiligo. The company's patented and proprietary platform technology provides treatment solutions derived from the regenerative properties of a patient's own skin. Its lead product is RECELL System, a device that enables healthcare professionals to produce a suspension of Spray-On Skin cells using a small sample of the patient's own skin for use in the treatment of acute thermal burns in patients eighteen years and older. The company has a research collaboration with the University of Colorado School of Medicine to establish and explore development of a spray-on treatment for patients with epidermolysis bullosa; and a research collaboration with Houston Methodist Research Institute to explore novel approaches for skin rejuvenation. The company was formerly known as AVITA Therapeutics, Inc. and changed its name to AVITA Medical Inc. in December 2020. AVITA Medical Inc. is based in Valencia, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Crowe SuzanneDirectorSep 20Buy17.081,06618,2074,112Sep 21 04:30 PM
PERRY MICHAEL SChief Executive OfficerSep 01Sale20.6811,220232,030237,638Sep 07 04:05 PM
PERRY MICHAEL SChief Executive OfficerJun 02Sale17.3323,000398,590225,104Jun 04 04:06 PM